Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Promotion of Breastfeeding Intervention Trial (PROBIT)

This study has been completed.
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
European Union EarlyNutrition program
University of Bristol
Information provided by (Responsible Party):
Emily Oken, Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT01561612
First received: March 20, 2012
Last updated: October 9, 2013
Last verified: October 2013

March 20, 2012
October 9, 2013
June 1996
December 1998   (final data collection date for primary outcome measure)
Gastrointestinal tract infection [ Time Frame: 12 months of age ] [ Designated as safety issue: No ]
Occurrence of 1 or more episodes of gastrointestinal tract infection
Same as current
Complete list of historical versions of study NCT01561612 on ClinicalTrials.gov Archive Site
  • Maternal adiposity [ Time Frame: 6.5 and 11.5 years postpartum ] [ Designated as safety issue: No ]
  • Child adiposity [ Time Frame: Throughout childhood ] [ Designated as safety issue: No ]
  • asthma [ Time Frame: 6.5 and 16 years ] [ Designated as safety issue: No ]
  • cognition [ Time Frame: 6.5 and 16 years ] [ Designated as safety issue: No ]
  • dental caries [ Time Frame: 6.5 years ] [ Designated as safety issue: No ]
  • child behavior [ Time Frame: 6.5 years ] [ Designated as safety issue: No ]
  • vision [ Time Frame: 16 years ] [ Designated as safety issue: No ]
  • lung function [ Time Frame: 16 years ] [ Designated as safety issue: No ]
  • IGF-1 [ Time Frame: Age 11.5 years ] [ Designated as safety issue: No ]
    IGF from dried bloodspots
  • child height [ Time Frame: throughout childhood ] [ Designated as safety issue: Yes ]
    Research measures of length/height
  • adiponectin [ Time Frame: age 11.5 years ] [ Designated as safety issue: No ]
    adiponectin from dried bloodspot
  • Apo A1 [ Time Frame: Child age 11.5 years ] [ Designated as safety issue: No ]
    Apo A1 in dried bloodspots
  • glucose [ Time Frame: child age 11.5 years ] [ Designated as safety issue: No ]
    fingerstick glucose measured by glucometer
  • insulin [ Time Frame: child age 11.5 years ] [ Designated as safety issue: No ]
    insulin measured on dried blood spots
  • Apo B [ Time Frame: Child age 11.5 years ] [ Designated as safety issue: No ]
    Apo B measured in dried blood spots
  • Child blood pressure [ Time Frame: throughout childhood ] [ Designated as safety issue: No ]
    Research measures of blood pressure at ages 6.5, 11.5 and 16 years
  • Maternal blood pressure [ Time Frame: 11.5 years postpartum ] [ Designated as safety issue: No ]
    Research measure of maternal blood pressure
  • Child metabolic syndrome [ Time Frame: Age 11.5 years ]
  • Child growth [ Time Frame: Throughout childhood ] [ Designated as safety issue: No ]
    Growth in weight, length, weight for length, BMI, and other measures
  • Respiratory tract infections [ Time Frame: to age 12 months and throughout childhood ] [ Designated as safety issue: No ]
    Number of respiratory infections, from review of medical record
  • Atopic Eczema [ Time Frame: Throughout childhood ] [ Designated as safety issue: No ]
    Eczema from review of medical record, parent report,and direct examination
  • Atopy [ Time Frame: Age 6.5 years ] [ Designated as safety issue: No ]
    Skinprick tests for allergy
  • Eating Attitudes [ Time Frame: Age 11.5 years ] [ Designated as safety issue: No ]
    Children's Eating Attitudes Test (ChEAT) Questionnaire
  • Maternal adiposity [ Time Frame: 11 years postpartum ] [ Designated as safety issue: No ]
  • Child adiposity [ Time Frame: 6 and 11.5 years ] [ Designated as safety issue: No ]
  • asthma [ Time Frame: 6.5 and 16 years ] [ Designated as safety issue: No ]
  • cognition [ Time Frame: 6.5 and 16 years ] [ Designated as safety issue: No ]
  • dental caries [ Time Frame: 6.5 years ] [ Designated as safety issue: No ]
  • child behavior [ Time Frame: 6.5 years ] [ Designated as safety issue: No ]
  • vision [ Time Frame: 16 years ] [ Designated as safety issue: No ]
  • lung function [ Time Frame: 16 years ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Promotion of Breastfeeding Intervention Trial
Breastfeeding Promotion RCT and Child Metabolic Syndrome

The overall goal of the PROBIT study is to investigate the influence of a randomized breastfeeding promotion intervention designed to increase the duration and exclusivity of breastfeeding ("the breastfeeding promotion intervention") on the development of maternal and child health outcomes. The hypothesis is that randomization to the intervention will be associated with lower child adiposity, lower risk of asthma and atopy, improved lung function, and improved cognitive outcomes.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Effect of Breastfeeding on Maternal and Child Health Outcomes
Behavioral: Breastfeeding promotion and support
Breastfeeding promotion and support according to the World Health Organization's Baby Friendly Hospital Initiative
  • Experimental: Intervention
    Breastfeeding promotion according to World Health Organization's Baby Friendly Hospital Initiative
    Intervention: Behavioral: Breastfeeding promotion and support
  • No Intervention: Control
    Usual care

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
17046
Not Provided
December 1998   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Birth at one of 34 Maternity Hospitals in Republic of Belarus
  • Breastfeeding initiated at birth, with no contraindications to breastfeeding
  • Apgar score >=5 at 5 minutes
  • Full term gestation
  • Birth weight > 2500g
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Belarus
 
NCT01561612
190250, R01HD050758, FOOD-DT-2005-007036, G0600705, K24HD069408, MOP-53155
No
Emily Oken, Harvard Pilgrim Health Care
Harvard Pilgrim Health Care
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Canadian Institutes of Health Research (CIHR)
  • European Union EarlyNutrition program
  • University of Bristol
Principal Investigator: Emily Oken, MD Harvard Pilgrim Health Care
Principal Investigator: Richard M Martin, MD University of Bristol
Harvard Pilgrim Health Care
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP